Cite
HARVARD Citation
Mesa, R. et al. (2017). Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. Cancer. 123 (3), pp. 449-458. [Online].